Τομέας Κλινικοεργαστηριακός

103. Halapas A, Lembessis P, Mourouzis I, Pantos C, Cokkinos DV, Sourla A, Koutsilieris M. Experimental hyperthyroidism increases
expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular
myocardium of the Langendorff ischaemia-reperfusion model. Exp Physiol. 2008 Feb; 93(2):237-46. Impact factor=3,014.
104. Labrie F, Koutsilieris M. The 12th International Congress on Hormonal Steroids and Hormones & Cancer. PrefacE J Steroid
Biochem Mol Biol. 2008 Feb; 108(3-5):179. Impact factor=2,799.
105. Halapas A, Zacharoulis A, Theocharis S, Karavidas A, Korres D, Papadopoulos K, Katopodis H, Stavropoulou A, Lembessis
P, Xiromeritis C, Zacharoulis A, Koutsilieris M. Serum levels of the osteoprotegerin, receptor activator of nuclear factor
kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months
after acute myocardial infarction. Clin Chem Lab Med. 2008; 46(4):510-6. Impact factor=1,741.
106. Philippou A, Stavropoulou A, Sourla A, Pissimissis N, Halapas A, Maridaki M, Koutsilieris M. Characterization of a rabbit
antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain. In Vivo.
2008 Jan-Feb; 22(1):27-35. Impact factor=1,604.
107. Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M. Defects in insulin signaling pathways
in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). J Steroid Biochem Mol Biol.
2008 Apr; 109(3-5):242-6. Impact factor=2,799.
108. Msaouel P, Pissimissis N, Halapas A, Koutsilieris M. Mechanisms of bone metastasis in prostate cancer: clinical implications.
Best Pract Res Clin Endocrinol Metab. 2008 Apr; 22(2):341-55. Impact factor=3,805.
109. Papageorgiou E, Pitulis N, Manoussakis M, Lembessis P, Koutsilieris M. Rosiglitazone attenuates insulin-like growth factor
1 receptor survival signaling in PC-3 cells. Mol Med. 2008 Jul-Aug; 14(7-8):403-11. Impact factor=2,078.
110. Halapas A, Pissimissis N, Lembessis P, Rizos I, Rigopoulos AG, Kremastinos DT, Koutsilieris M. Molecular diagnosis of
the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opin Ther
Targets. 2008 Jul; 12(7):821-36. Impact factor=3,333.
111. Makri A, Pissimissis N, Lembessis P, Polychronakos C, Koutsilieris M. The kisspeptin (KiSS-1)/GPR54 system in cancer
biology. Cancer Treat Rev. 2008 Dec; 34(8):682-92. Impact factor=4,539.
112. Haramis G, Zhou Z, Pyriochou A, Koutsilieris M, Roussos C, Papapetropoulos A. cGMP-independent anti-tumour actions
of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. Br J Pharmacol. 2008 Nov; 155(6):804-
13. Impact factor=3,767.
113. Mariolis A, Mihas C, Alevizos A, Papathanasiou M, Mariolis-Sapsakos T, Marayiannis K, Koutsilieris M. Evaluation of a
clinical attachment in Primary Health Care as a component of undergraduate medical education. Med Teach. 2008;
30(7):e202-7. .Impact factor=1,229
114. Halapas A, Armakolas A, Koutsilieris M. Autophagy: a target for therapeutic interventions in myocardial pathophysiology.
Expert Opin Ther Targets. 2008 Dec; 12(12):1509-22. Impact factor=3,333.
115. Nezos A, Lembessis P, Sourla A, Pissimissis N, Gogas H, Koutsilieris M. Review: Molecular markers detecting circulating
melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevancE Clin
Chem Lab Med. 2008 Dec 5. Impact factor=1,741.
116. Schulpis KH, Tsironi M, Skenderi K, Lazaropoulou C, Parthimos N, Reclos G, Goussetis E, Tsakiris S, Papassotiriou I.
Dramatic reduction of erythrocyte glucose-6-phosphate dehydrogenase activity in athletes participating in the ultradistance
foot race "Spartathlon".Scand J Clin Lab Invest. 2008; 68(3):228-32. Impact factor=1,235.
117. Schulpis KH, Papakonstantinou ED, Vlachos GD, Vlachos DG, Antsaklis A, Papassotiriou I, Tsakiris S. The effect of the
mode of delivery on the maternal-neonatal carnitine blood levels and antioxidant status. Clin Chem Lab Med. 2008 Mar
10. Impact factor=1,741.
118. Vlachos DG, Schulpis KH, Parthimos T, Mesogitis S, Vlachos GD, Antsaklis A, Tsakiris S. Maternal-neonatal erythrocyte
membrane Na(+), K (+)-ATPase and Mg (2+)-ATPase activities in relation to the mode of delivery. Eur J Appl Physiol.
2008 Jul; 103(5):501-8. Impact factor=1,752.
119. Vlachos DG, Schulpis KH, Parthimos T, Mesogitis S, Vlachos GD, Partsinevelos GA, Antsaklis A, Tsakiris S. The effect of
the mode of delivery on the maternal-neonatal erythrocyte membrane acetylcholinesterase activity. Clin Biochem. 2008
Jul; 41(10-11):818-23. Impact factor=2,072.
120. Liapi C, Feskou I, Zarros A, Carageorgiou H, Galanopoulou P, Tsakiris S. Equilibrated diet restores the effects of early age
choline-deficient feeding on rat brain antioxidant status and enzyme activities: the role of homocysteine, L-phenylalanine
and L-alaninE Metab Brain Dis. 2008 Sep; 23(3):289-301. Impact factor=1,831.
121. Zarros A, Theocharis S, Skandali N, Tsakiris S. Effects of fulminant hepatic encephalopathy on the adult rat brain antioxidant
status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg (2+)-ATPase: comparison of the enzymes'
response to in vitro treatment with ammonia. Metab Brain Dis. 2008 Sep; 23(3):255-64. Impact factor=1,831.
122. Liapi C, Zarros A, Galanopoulou P, Theocharis S, Skandali N, Al-Humadi H, Anifantaki F, Gkrouzman E, Mellios Z, Tsakiris
S. Effects of short-term exposure to manganese on the adult rat brain antioxidant status and the activities of acetylcholinesterase,
(Na,K)-ATPase and Mg-ATPase: modulation by L-cysteinE Basic Clin Pharmacol Toxicol. 2008 Aug;
103(2):171-5. Impact factor=1,821.
2124 ¸êèåóç ÅóùôåñéêÞò Áîéïëüãçóçò (Ðñüôõðï ó÷Þìá)